’We are in talks with leading pharma companies to introduce Elores in South Africa and later…
Dr Manu Chaudhary, Joint Managing Director and Director—Research, Venus Remedies shares the company's marketing and branding…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Archive
Pharmexcil invites comments from industry on EU directive notification
Final notification to be issued by February 20-21, 2013
Q3 results posts ups and downs in India pharma sector
Indian pharma companies have posted their third quarter results. Express Pharma highlights the results
New rules on compensation to make clinical trials in India ‘virtually impossible’: ISCR
Notification goes against consensus reached in stakeholder meetings on two crucial criteria, alleges ISCR
Medicines Compendium expands global reach through new expert committees, enhanced website
Experts from Argentina, Bangladesh, Brazil, China, Korea, Pakistan and the UK reflect growth of the MC
Marck Biosciences takes private equity route with Tata Capital
To invest Rs 80 crores in new project
Glenmark initiates IND enabling studies of novel monoclonal antibody targeting OX40
GBR 830 is the first antagonistic antibody targeting OX40 and is a potential Global First-in-class molecule
M&A activity in pharma sector focuses on expanding product offerings
January 2013 registers slight increase in volume terms and decrease in value terms
STEM-2013 redefines stem cell research in India
Researchers from France, Argentina and Brazil provided useful inputs about the regulatory scenario
GIPC-2013 sees congregation of IP experts
More than 300 speakers from 30 countries participated in the event